Sign in or create an account to add this stock to your watchlist.
About Creative Medical Tech (OTCMKTS:CELZ)
Creative Medical Technology Holdings, Inc., through its subsidiaries, engages in the stem cell research and developing applications to treat male sexual dysfunction and related issues. The company markets its erectile dysfunction (ED) treatment under the Caverstem name to physicians for use with their patients suffering from ED. Creative Medical Technology Holdings, Inc. was incorporated in 1998 and is based in Phoenix, Arizona. Creative Medical Technology Holdings, Inc. is a subsidiary of Creative Medical Health, Inc.
Industry, Sector and Symbol
Trailing P/E RatioN/A
Forward P/E RatioN/A
Sales & Book Value
Price / SalesN/A
Price / CashN/A
Price / BookN/A
EPS (Most Recent Fiscal Year)N/A
Return on EquityN/A
Return on Assets-81.95%
Creative Medical Tech (OTCMKTS:CELZ) Frequently Asked Questions
What is Creative Medical Tech's stock symbol?
Creative Medical Tech trades on the OTCMKTS under the ticker symbol "CELZ."
Who are some of Creative Medical Tech's key competitors?
Some companies that are related to Creative Medical Tech include Port Erin Biopharma Investments (PEBI), Arno Therapeutics (ARNI), 9342-8530 Quebec (DGCRF), Proteonomix (PROT), Medican Enterprises (MDCN), Devonian Health Group (GSD), Galena Biopharma (SLS), Naturally Splendid (NSP), Novacyt (NCYT), Nuformix (NFX), Sirona Biochem (SBM) and Synthetic Biologics (SYN).
Who are Creative Medical Tech's key executives?
Creative Medical Tech's management team includes the folowing people:
- Mr. Timothy Warbington, Chairman, Pres & CEO (Age 56)
- Mr. Donald Dickerson, Chief Financial Officer, Sr. Vice-Pres and Director (Age 53)
- Dr. Thomas E. Ichim, Chief Scientific Officer and Director (Age 42)
- Dr. Annette Marleau, Sr. Vice-Pres (Age 43)
Has Creative Medical Tech been receiving favorable news coverage?
News stories about CELZ stock have been trending positive recently, according to Accern. Accern identifies positive and negative press coverage by reviewing more than 20 million news and blog sources in real time. Accern ranks coverage of companies on a scale of -1 to 1, with scores closest to one being the most favorable. Creative Medical Tech earned a media sentiment score of 0.31 on Accern's scale. They also assigned news stories about the company an impact score of 46.43 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the company's share price in the immediate future.
How do I buy shares of Creative Medical Tech?
Shares of CELZ can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Creative Medical Tech's stock price today?
One share of CELZ stock can currently be purchased for approximately $0.0140.
How big of a company is Creative Medical Tech?
Creative Medical Tech has a market capitalization of $347,922.00.
How can I contact Creative Medical Tech?
Creative Medical Tech's mailing address is 2017 W Peoria Ave, PHOENIX, AZ 85029-4916, United States. The company can be reached via phone at +1-602-6807439.
MarketBeat Community Rating for Creative Medical Tech (CELZ)MarketBeat's community ratings are surveys of what our community members think about Creative Medical Tech and other stocks. Vote "Outperform" if you believe CELZ will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CELZ will underperform the S&P 500 over the long term. You may vote once every thirty days.
Creative Medical Tech (OTCMKTS:CELZ) Analyst Ratings History
(Data available from 5/27/2016 forward)
Creative Medical Tech (OTCMKTS:CELZ) Dividend History by Quarter
(Data available from 1/1/2013 forward)
|Announced||Period||Amount||Yield||Ex-Dividend Date||Record Date||Payable Date|
Creative Medical Tech (OTCMKTS CELZ) Insider Trading and Institutional Ownership History
Creative Medical Tech (OTCMKTS CELZ) Insider Trading History
(Data available from 1/1/2013 forward)
|Transaction Date||Insider Name||Title||Buy/Sell||Number of Shares||Average Share Price||Total Transaction||Shares Held After Transaction||Details|
|8/29/2017||Creative Medical Health Inc.||Major Shareholder||Sell||5,000||$0.20||$1,000.00||58,655,927|| |
|6/5/2017||Creative Medical Health Inc.||Major Shareholder||Sell||5,300||$0.30||$1,590.00||58,608,727|| |
|6/2/2017||Creative Medical Health Inc.||Major Shareholder||Sell||5,700||$0.41||$2,337.00||58,613,427|| |
|5/18/2017||Creative Medical Health Inc.||Major Shareholder||Sell||1,400||$0.45||$630.00||58,616,927|| |
|12/31/2016||Creative Medical Health Inc.||Major Shareholder||Sell||2,935,609||$0.10||$293,560.90||64,996,667|| |
Creative Medical Tech (OTCMKTS CELZ) News Headlines
Creative Medical Tech (OTCMKTS:CELZ) SEC Filings
This page is loading this company's SEC Filings. Please wait...
Financials are not available for this stock.
Creative Medical Tech (OTCMKTS CELZ) Stock Chart for Sunday, May, 27, 2018